Submitted by Anonymous (not verified) on 2 October 2024 - 12:57
Opinion/decision on a Paediatric investigation plan (PIP): Wegovy, semaglutide, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism, PIP number: P/0296/2023
Source: